USANA Health Sciences (NYSE:USNA) Updates FY 2025 Earnings Guidance

USANA Health Sciences (NYSE:USNA) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 2.350-3.000 for the period, compared to the consensus estimate of 2.870. The company issued revenue guidance of $920.0 million-$1.0 billion, compared to the consensus revenue estimate of $934.5 million.

Analysts Set New Price Targets

Several research analysts have recently issued reports on USNA shares. DA Davidson decreased their price objective on shares of USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a report on Thursday. Sidoti lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th. Finally, StockNews.com cut USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th.

USANA Health Sciences Stock Performance

Shares of NYSE:USNA traded down $4.64 during trading hours on Thursday, hitting $28.57. 554,986 shares of the company’s stock traded hands, compared to its average volume of 163,121. The company’s fifty day simple moving average is $33.62 and its two-hundred day simple moving average is $36.61. The company has a market cap of $544.54 million, a price-to-earnings ratio of 10.10, a price-to-earnings-growth ratio of 0.93 and a beta of 0.87. USANA Health Sciences has a 52 week low of $27.71 and a 52 week high of $50.32.

USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, topping analysts’ consensus estimates of $0.49 by $0.15. The firm had revenue of $213.61 million during the quarter, compared to analysts’ expectations of $208.82 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. On average, analysts anticipate that USANA Health Sciences will post 2.45 EPS for the current fiscal year.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.